Dynamic Monitoring of Urinary Electrolytes
2 other identifiers
interventional
40
1 country
1
Brief Summary
This interventional device feasibility study evaluates the operational feasibility of a prototype urinary electrolyte monitoring device in healthy adults aged 18 to 60 years. Urine samples will be collected during protocol-defined dietary intervention conditions and free-living conditions to determine whether the prototype device can generate complete urinary sodium, chloride, potassium, magnesium, and calcium measurement results without device malfunction, sample-processing failure, unreadable signal output, or repeat device operation. Dietary intervention conditions are used to provide physiologic variation in urinary electrolyte levels and to create testing conditions for the prototype device. The primary outcome is the valid measurement rate of the prototype device across collected urine samples. Secondary outcomes will summarize changes in urinary electrolyte levels following dietary interventions and within-participant variability under free-living conditions. Participants will provide baseline anthropometric and physiological data, including height, weight, age, and blood pressure, along with baseline fasting morning urine samples. Participants will consume assigned standardized meals or provide urine samples under free-living conditions, depending on study arm assignment. Longitudinal urine samples will be collected at protocol-defined time points, such as post-prandial intervals or other scheduled collection times during the study period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Jul 2026
Shorter than P25 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 25, 2026
CompletedFirst Posted
Study publicly available on registry
July 15, 2026
CompletedStudy Start
First participant enrolled
July 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 20, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2026
July 15, 2026
July 1, 2026
1 month
June 25, 2026
July 14, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Prototype Device Valid Measurement Rate for Urinary Electrolyte Analysis
Percentage of all collected urine samples for which the prototype device produces a complete urinary sodium, chloride, potassium, magnesium, and calcium measurement result without device malfunction, sample-processing failure, unreadable signal output, or need for repeat device operation. A valid measurement rate of 80% or higher will be considered to meet the protocol-defined feasibility criterion.
Up to 2 weeks after study arm assignment.
Secondary Outcomes (5)
Change from baseline in urinary sodium, chloride, potassium, magnesium, and calcium levels following the high-fruit dietary intervention
Baseline, 1 hour, 2 hours, 3 hours, and 4 hours after the high-fruit dietary intervention.
Change from baseline in urinary sodium, chloride, potassium, magnesium, and calcium levels following the high-nut dietary intervention
Baseline, 1 hour, 2 hours, 3 hours, and 4 hours after the high-nut dietary intervention.
Change from baseline in urinary sodium, chloride, potassium, magnesium, and calcium levels following the calcium supplementation dietary intervention
Baseline, 1 hour, 2 hours, 3 hours, and 4 hours after the calcium supplementation dietary intervention.
Change from baseline in urinary sodium, chloride, potassium, magnesium, and calcium levels following the DASH dietary intervention
Baseline and daily for up to 2 weeks during the DASH dietary intervention.
Within-participant variability in urinary sodium, chloride, potassium, magnesium, and calcium levels under free-living conditions
Daily for up to 1 week under free-living conditions.
Study Arms (5)
fruit diet (for potassium intake)
EXPERIMENTALnut diet (for magnesium intake)
EXPERIMENTALCalcium supplement diet (for calcium intake)
EXPERIMENTALDASH Diet (for low-salt and high-fruit intake)
EXPERIMENTALUncontrol
EXPERIMENTALInterventions
Urine is collected and tested on the device.
Participants will consume assigned standardized meals including fruit.
Participants will consume assigned standardized meals including nut.
Participants will consume assigned standardized meals including calcium supplements.
Participants will consume assigned low salt high fruit meals following DASH diet guidance.
Eligibility Criteria
You may qualify if:
- Adults aged between 18- and 60-year-old
- Willing to join and complete the study
You may not qualify if:
- Medical conditions, such as liver, kidney, gastrointestinal, or systemic diseases;
- Drug taking or use within two weeks;
- Pregnant women;
- Lack of access to a smartphone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Westlake University
Hangzhou, Zhejiang, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- The anticipated 40 participates are allocated to 5 parellel arms to verify the feasibility of device for testing 5 different urinary electrolytes to ensure 5-8 participates in each arms.
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 25, 2026
First Posted
July 15, 2026
Study Start
July 20, 2026
Primary Completion (Estimated)
August 20, 2026
Study Completion (Estimated)
September 30, 2026
Last Updated
July 15, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share